Synonyms: | |
Status: | Phase 2 |
Entry Type: | Small molecule |
Molecule Category: | UKNOWN |
UNII: | G786V328X6 |
InChI Key | LTSUMTMGJHPGFX-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C21H15ClF3NO2 |
Molecular Weight | 405.8 |
AlogP | 5.64 |
Hydrogen Bond Acceptor | 2.0 |
Hydrogen Bond Donor | 1.0 |
Number of Rotational Bond | 5.0 |
Polar Surface Area | 50.19 |
Molecular species | ACID |
Aromatic Rings | 3.0 |
Heavy Atoms | 28.0 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2C
Cytochrome P450 2C19
|
- | 43000 | - | - | - | |
Enzyme
Cytochrome P450
Cytochrome P450 family 3
Cytochrome P450 family 3A
Cytochrome P450 3A4
|
- | 15000 | - | - | - | |
Enzyme
Phosphodiesterase
Phosphodiesterase 4
Phosphodiesterase 4B
|
- | 2013 | - | - | - | |
Enzyme
Phosphodiesterase
Phosphodiesterase 4
Phosphodiesterase 4D
|
- | 127 | - | - | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Alzheimer Disease | 2 | D000544 | ClinicalTrials |
Fragile X Syndrome | 2 | D005600 | ClinicalTrials |
Resources | Reference |
---|---|
ChEMBL | CHEMBL4541964 |
FDA SRS | G786V328X6 |
Guide to Pharmacology | 10451 |
PDB | KR7 |
SureChEMBL | SCHEMBL15660260 |